Midterm Pediatric Hematology-Oncology CME

About this event

The Midterm Pediatric Hematology-Oncology CME, taking place at the Courtyard by Marriott in Madurai, India, is a pivotal gathering for professionals in the field of pediatric hematology and oncology. This year's theme centers around 'Contemporary Advances in Non-Hodgkin Lymphoma' and 'Insights into Hemolytic Anemias (excluding Hemoglobinopathies)', showcasing the commitment to advancing knowledge in areas marked by evolving evidence, complex diagnostics, and innovative therapies. The program is meticulously designed to incorporate the latest research findings, expert insights, and practical applications that are pertinent to daily clinical practice. Delegates will benefit from an array of high-quality lectures, engaging panel discussions, and interactive learning formats aimed at enhancing critical thinking and clinical decision-making. The CME will also feature a dedicated segment for trainees, including a stimulating quiz designed for Pediatric Hematology and Oncology trainees, encouraging their active involvement. Special sessions for pediatricians and nursing professionals are incorporated to bridge knowledge gaps and promote collaborative learning across disciplines. Participants will not only gain insights into advanced topics such as low-dose chemo-immunotherapy versus standard chemotherapy, T-cell lymphoma, and the complexities of hemolytic anemia, but also have opportunities to explore the rich cultural heritage of Madurai, famous for its architectural wonders and archaeological significance. The event is organized by the Pediatric Hematology & Oncology Chapter of the Indian Academy of Pediatrics in collaboration with Meenakshi Mission Hospital. This collaborative effort underscores the importance of nurturing young minds in the field through knowledge-sharing and hands-on workshops. Attendees can look forward to expert-led sessions addressing real-world scenarios, challenges in management, and advanced treatment modalities, including HSCT and gene therapy